Free-to-Total Prostate Specific Antigen Ratio as a Single Test for Detection of Significant Stage T1c Prostate Cancer
Authors:
- 1 September 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 156 (3) , 1042-1049
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening1995
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- The Lack of Predictive Value of Prostate Specific Antigen Density in the Detection of Prostate Cancer in Patients with Normal Rectal Examinations and Intermediate Prostate Specific Antigen LevelsJournal of Urology, 1995
- A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer1994
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987